EUVIMEDSkopri EUVIMED
Crossref

Investigating the Mechanism by Which RMRP Regulates Diabetic Peripheral Neuropathy via the miR‐3142

Mimi Wang, Tenghui Fu, Jinfeng Yang, Wei Yan, Menglie Zhang

Synapse · 2025

DOI: 10.1002/syn.70034 ↗

At a glance

Journal article in Synapse, 2025. Written by Mimi Wang and 4 co-authors. Institution: Department of Endocrinology, Xuzhou Tongshan District Traditional Chinese Medicine Hospital, Xuzhou, China. Major MEDLINE topics: MicroRNAs, Diabetic Neuropathies, Schwann Cells, RNA, Long Noncoding. 37 references. Funded by: Xuzhou Chinese Medicine Science and Technology Development Program Project.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

This study aims to investigate the role of long noncoding RNA RMRP in diabetic peripheral neuropathy (DPN) and its potential mechanisms. We used high glucose (HG) treatment on Schwann cells (SCs) and established a DPN rat model to study the role of RMRP in DPN. RT‐qPCR was employed to assess the levels of RMRP and miR‐3142. The targeting relationship between RMRP and miR‐3142 was verified through dual‐luciferase reporter assays, RIP assays, and RNA pull‐down experiments. CCK‐8 assays and flow cytometry were used to evaluate cell proliferation and apoptosis. The von Frey test and thermal stimulus apparatus measured the mechanical withdrawal threshold (MWT) and thermal withdrawal latency (TWL) in rats. In addition, the motor nerve conduction velocity (MNCV) and sensory nerve conduction velocity (SNCV) of the rats were assessed. RMRP was abnormally expressed in both HG‐treated SCs and DPN rats. Inhibition of RMRP significantly alleviated the reduction in SCs proliferation and the increase in apoptosis induced by HG, while also reducing oxidative stress and neuroinflammation levels. In DPN rats, inhibition of RMRP improved MWT and TWL and enhanced nerve conduction velocity, whereas inhibition of miR‐3142 diminished the protective effects of si‐RMRP. Inhibiting RMRP can relieve DPN‐related oxidative stress and cell inflammation, as well as reduce pain hypersensitivity and the decline in nerve conduction velocity in rats by upregulating miR‐3142.

Subjects

MeSH terms (MEDLINE)

MicroRNAsDiabetic NeuropathiesSchwann CellsRNA, Long NoncodingAnimalsRatsMaleRats, Sprague-DawleyNeural ConductionApoptosisCell ProliferationGlucoseDiabetes Mellitus, ExperimentalOxidative Stress

Author keywords

RMRPdiabetic peripheral neuropathymiR‐3142neuroinflammationoxidative stress

Substances

MicroRNAsRNA, Long NoncodingGlucose

Authors and institutions

  • Department of Endocrinology, Xuzhou Tongshan District Traditional Chinese Medicine Hospital, Xuzhou, China.
  • Department of Emergency Medicine, Xuzhou Traditional Chinese Medicine Hospital, Xuzhou, China.
  • Department of Neurology, Xuzhou Tongshan District Traditional Chinese Medicine Hospital, Xuzhou, China.

Funding

  • Xuzhou Chinese Medicine Science and Technology Development Program Project

Cite

APA

Wang, M., Fu, T., Yang, J., Yan, W., & Zhang, M. (2025). Investigating the Mechanism by Which RMRP Regulates Diabetic Peripheral Neuropathy via the miR‐3142. Synapse. https://doi.org/10.1002/syn.70034

Vancouver

Wang M, Fu T, Yang J, Yan W, Zhang M. Investigating the Mechanism by Which RMRP Regulates Diabetic Peripheral Neuropathy via the miR‐3142. Synapse. 2025. doi:10.1002/syn.70034

BibTeX
@article{Wang2025,
  author = {Wang, Mimi and Fu, Tenghui and Yang, Jinfeng and Yan, Wei and Zhang, Menglie},
  title = {Investigating the Mechanism by Which RMRP Regulates Diabetic Peripheral Neuropathy via the miR‐3142},
  journal = {Synapse},
  year = {2025},
  doi = {10.1002/syn.70034}
}
Start for free →